18
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Pharmacokinetic Analysis of Pegylated Megakaryocyte Growth and Development Factor in Humans

, , , , , , & show all
Pages 215-226 | Received 01 Jul 1999, Accepted 01 Jul 2000, Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

G Pasut, A Guiotto & FM Veronese. (2004) Protein, peptide and non-peptide drug PEGylation for therapeutic application. Expert Opinion on Therapeutic Patents 14:6, pages 859-894.
Read now

Articles from other publishers (7)

Jay Tibbitts, Joy A. Cavagnaro, Christine A. Haller, Ben Marafino, Paul A. Andrews & John T. Sullivan. (2010) Practical approaches to dose selection for first-in-human clinical trials with novel biopharmaceuticals. Regulatory Toxicology and Pharmacology 58:2, pages 243-251.
Crossref
F.M. Veronese, G. Pasut, S. Drioli & G.M. Bonora. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics 265 288 .
Gianfranco Pasut & Francesco M. Veronese. (2009) PEG conjugates in clinical development or use as anticancer agents: An overview. Advanced Drug Delivery Reviews 61:13, pages 1177-1188.
Crossref
Gianfranco Pasut & Francesco M. Veronese. 2006. Polymer Therapeutics I. Polymer Therapeutics I 95 134 .
Hideji Tanaka, Hirotaka Takama, Yasumasa Arai, Junichi Azuma, Ryuzo Ohno, Yasuo Ikeda & Hideaki Mizoguchi. (2004) Pharmacokinetics of pegylated recombinant human megakaryocyte growth and development factor in healthy volunteers and patients with hematological disorders. European Journal of Haematology 73:4, pages 269-279.
Crossref
Olaf Kinstler, Graham Molineux, Michael Treuheit, David Ladd & Colin Gegg. (2002) Mono-N-terminal poly(ethylene glycol)–protein conjugates. Advanced Drug Delivery Reviews 54:4, pages 477-485.
Crossref
Russell L. BasserElizabeth O'FlahertyMichael GreenMaria EdmondsJanet NicholDora M. MenchacaBrian CohenC. Glenn Begley. (2002) Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 99:7, pages 2599-2602.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.